AC Immune
ACIU
34 hedge funds and large institutions have $44.3M invested in AC Immune in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
28% more call options, than puts
Call options by funds: $115K | Put options by funds: $90K
0.26% more ownership
Funds ownership: 16.52% → 16.78% (+0.26%)
3% less funds holding
Funds holding: 35 → 34 (-1)
11% less capital invested
Capital invested by funds: $49.8M → $44.3M (-$5.52M)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$866K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$346K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$81.4K |
| 4 |
Mariner
Overland Park,
Kansas
|
+$63K |
| 5 |
KCIA
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
|
+$26.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$532K |
| 2 |
Renaissance Technologies
New York
|
-$125K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52.1K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$45K |
| 5 |
BlackRock
New York
|
-$32.3K |
ACIU Hedge Fund Activity: Q3 2022 in Review
34 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2022, worth a combined $44.3M — down 11% from $49.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ACIU and 4 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 8 added.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $866K. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $532K sold.
- 34 institutional investors held AC Immune (ACIU) as of Q3 2022, down from 35 in Q2 2022.
- Funds reported $44.3M of AC Immune stock for Q3 2022, down 11% quarter-over-quarter.
- 4 funds opened new AC Immune positions in Q3 2022 and 5 closed out, a net change of -1 holder.
- The largest AC Immune buyer in Q3 2022 was Avidity Partners Management, an estimated $866K added.
- The largest AC Immune seller in Q3 2022 was Assenagon Asset Management, an estimated $532K sold.
Based on aggregated 13F filings for Q3 2022.